Studies on the fate of 5-fluoro-1,3-bis(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FD-1), a new antitumor agent. I. Absorption, distribution, excretion and metabolism of FD-1 administered orally to rats

Kawaguchi, Y., Nakamura, Y., Sato, T., Takeda, S., Marunaka, T., & Fujii, S. (1978). Studies on the fate of 5-fluoro-1,3-bis(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FD-1), a new antitumor agent. I. Absorption, distribution, excretion and metabolism of FD-1 administered orally to rats. Yakugaku Zasshi, 98(4), 525–536. https://doi.org/10.1248/yakushi1947.98.4_525